People: iRhythm Technologies Inc (IRTC.OQ)

IRTC.OQ on NASDAQ Stock Exchange Global Select Market

17 Aug 2018
Change (% chg)

$-0.93 (-1.12%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Snyderman, Ralph 

Dr. Ralph Snyderman serves as Independent Director of the company. he is Chancellor Emeritus, James B. Duke Professor of Medicine, and Director of the Center for Research on Personalized Health Care at Duke University. From 1989 to 2004, he served as Chancellor for Health Affairs at Duke and was the founding CEO and President of the Duke University Health System. He was a venture partner with New Enterprise Associates from 2006 to 2009. He previously served on the boards of directors of The Procter and Gamble Company, Pharmaceutical Product Development, LLC (PPD), Trevena, Inc., Crescendo Bioscience, Inc. and Targacept, Inc. He currently serves on the boards of CareDx, Inc., Liquida Technologies, Inc., Purdue Pharma L.P., Sengenix, Inc., Linus Oncology, Inc., Veritas Collaborative Holdings, and Essential Health Solutions, Inc. Dr. Snyderman is a member of the Association of American Physicians, where he served as president from 2003 to 2004, the Association of American Medical Colleges, where he served as chair from 2001 to 2002, the National Academy of Medicine and the American Academy of Arts & Sciences. Dr. Snyderman holds a B.S. in Pre-Medical Studies from Washington College, an M.D. from the State University of New York, Downstate Medical Center, and completed an internship and residency in Medicine at Duke University.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 79,987
Long-Term Incentive Plans, USD --
All Other, USD 101,973
Fiscal Year Total, USD 181,960

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Abhijit Talwalkar


Kevin King


Matthew Garrett


Karim Karti


David Vort


Derrick Sung

As Of  31 Dec 2017